Cleerly

Cleerly is an AI-driven coronary artery disease imaging platform for cardiology programs, analyzing coronary CT angiography to characterize plaque, stenosis, and atherosclerosis risk.

1. Clinical role: It supports cardiac imaging and risk stratification rather than autonomous cardiology, with cardiologist review remaining essential for every interpretation and related treatment decision.
2. Best-fit environment: Programs with strong coronary CT volumes may benefit most from its focus on plaque characterization and cardiovascular risk assessment.
3. Implementation checks: Buyers should assess regulatory clearance scope, imaging fit, reporting integration, clinical validation evidence, and workflow readiness before broader deployment.
4. Commercial model: Pricing is sales-led and scoped per buyer rather than publicly posted, so teams should confirm service scope and support requirements.

A focused pilot can establish clinical workflow fit and implementation needs before a wider rollout.